The magistral phage

Jean Paul Pirnay; Gilbert Verbeken; Pieter Jan Ceyssens; Isabelle Huys; Daniel de Vos; Charlotte Ameloot; Alan Fauconnier

doi:10.3390/v10020064

The magistral phage

Jean Paul Pirnay, Gilbert Verbeken, Pieter Jan Ceyssens, Isabelle Huys, Daniel de Vos, Charlotte Ameloot, Alan Fauconnier

Onderzoeksoutput: Bijdrage aan een tijdschrift › Artikel › peer review

Samenvatting

Since time immemorial, phages—the viral parasites of bacteria—have been protecting Earth’s biosphere against bacterial overgrowth. Today, phages could help address the antibiotic resistance crisis that affects all of society. The greatest hurdle to the introduction of phage therapy in Western medicine is the lack of an appropriate legal and regulatory framework. Belgium is now implementing a pragmatic phage therapy framework that centers on the magistral preparation (compounding pharmacy in the US) of tailor-made phage medicines.

Originele taal-2	Engels
Artikelnummer	64
Tijdschrift	Viruses
Volume	10
Nummer van het tijdschrift	2
DOI's	https://doi.org/10.3390/v10020064
Status	Gepubliceerd - 6 feb. 2018

Toegang tot document

10.3390/v10020064

Andere bestanden en links

Link naar publicatie in Scopus

Citeer dit

@article{44beeba17b1148b895d548b0a9ab47ef,

title = "The magistral phage",

abstract = "Since time immemorial, phages—the viral parasites of bacteria—have been protecting Earth{\textquoteright}s biosphere against bacterial overgrowth. Today, phages could help address the antibiotic resistance crisis that affects all of society. The greatest hurdle to the introduction of phage therapy in Western medicine is the lack of an appropriate legal and regulatory framework. Belgium is now implementing a pragmatic phage therapy framework that centers on the magistral preparation (compounding pharmacy in the US) of tailor-made phage medicines.",

keywords = "Antibiotic, Antimicrobial resistance, Compounding pharmacy, Magistral preparation, Personalized medicine, Phage therapy, Regulatory framework",

author = "Pirnay, \{Jean Paul\} and Gilbert Verbeken and Ceyssens, \{Pieter Jan\} and Isabelle Huys and \{de Vos\}, Daniel and Charlotte Ameloot and Alan Fauconnier",

note = "Publisher Copyright: {\textcopyright} 2018 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2018",

month = feb,

day = "6",

doi = "10.3390/v10020064",

language = "English",

volume = "10",

journal = "Viruses",

issn = "1999-4915",

number = "2",

}

TY - JOUR

T1 - The magistral phage

AU - Pirnay, Jean Paul

AU - Verbeken, Gilbert

AU - Ceyssens, Pieter Jan

AU - Huys, Isabelle

AU - de Vos, Daniel

AU - Ameloot, Charlotte

AU - Fauconnier, Alan

PY - 2018/2/6

Y1 - 2018/2/6

N2 - Since time immemorial, phages—the viral parasites of bacteria—have been protecting Earth’s biosphere against bacterial overgrowth. Today, phages could help address the antibiotic resistance crisis that affects all of society. The greatest hurdle to the introduction of phage therapy in Western medicine is the lack of an appropriate legal and regulatory framework. Belgium is now implementing a pragmatic phage therapy framework that centers on the magistral preparation (compounding pharmacy in the US) of tailor-made phage medicines.

AB - Since time immemorial, phages—the viral parasites of bacteria—have been protecting Earth’s biosphere against bacterial overgrowth. Today, phages could help address the antibiotic resistance crisis that affects all of society. The greatest hurdle to the introduction of phage therapy in Western medicine is the lack of an appropriate legal and regulatory framework. Belgium is now implementing a pragmatic phage therapy framework that centers on the magistral preparation (compounding pharmacy in the US) of tailor-made phage medicines.

KW - Antibiotic

KW - Antimicrobial resistance

KW - Compounding pharmacy

KW - Magistral preparation

KW - Personalized medicine

KW - Phage therapy

KW - Regulatory framework

UR - https://www.scopus.com/pages/publications/85041865372

U2 - 10.3390/v10020064

DO - 10.3390/v10020064

M3 - Article

C2 - 29415431

AN - SCOPUS:85041865372

SN - 1999-4915

VL - 10

JO - Viruses

JF - Viruses

IS - 2

M1 - 64

ER -

The magistral phage

Samenvatting

Toegang tot document

Andere bestanden en links

Vingerafdruk

Citeer dit